New Delhi, Jan. 21 -- Central Drugs Laboratories have identified 74 drug samples, and State Drugs Testing Laboratories have identified 93 drug samples as Not of Standard Quality (NSQ) for the month of December 2025, a press note said.

Identification of drug samples as NSQ is based on the failure of a drug sample in one or more of the specified quality parameters. The failure is specific to the batch of drug products tested by the Government Laboratory and does not warrant any concerns about other drug products available in the market.

Further, in December 2025, four drug samples from North Zone, Ghaziabad; one from FDA Ahmedabad; one from Bihar; and one from Maharashtra were identified as spurious drugs, manufactured by unauthorised man...